Samarium Completed Phase 1 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00559429Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer